Blog - Page 784 of 5695 - QualityStocks

WednesdayJan 25, 2023 12:53 pm

QualityStocksNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Advances Novel Drug Candidate in Treating Alzheimer’s Symptoms

India Globalization Capital (NYSE American: IGC), in a historic first, has begun phase 2 clinical trials evaluating its flagship drug candidate, IGC-AD1, for the treatment of agitation in dementia from Alzheimer’s disease. “Company officials noted that, to their knowledge, this is the first natural low-dose THC-based compound to enter human trials for the treatment of symptoms such as agitation in dementia from Alzheimer’s disease. Currently there is no FDA-approved medication to treat agitation in Alzheimer’s,” reads a recent article. The piece quotes IGC CEO Ram Mukunda, who states, “We believe IGC-AD1 has the potential to revolutionize the treatment of the…

WednesdayJan 25, 2023 12:43 pm

QualityStocksNewsBreaks – CISO Global Inc. (NASDAQ: CISO) CEO Discusses Top-down Culture of Cybersecurity in ‘Shrimp Tank’ Interview

CISO Global (NASDAQ: CISO), an industry leader in managed cybersecurity and compliance services, was featured on a recent episode of “The Shrimp Tank.” The company’s CEO David Jemmett joined podcast host Ted Jenkin to discuss CISO Global’s approach to cybersecurity, explaining that successful cybersecurity must be woven into the fabric of an organization, encompassing and transforming the entity’s culture. During the interview, Jemmett shared that, although cybersecurity has become a well-known subject in today’s business world, surprisingly few companies are doing enough about this very real threat. “A lot of folks are not addressing [cybersecurity]… They don’t want to know…

WednesdayJan 25, 2023 11:37 am

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Announces Launch of Its Next-Gen SmartSole in Sweden

MetAlert (OTC: MLRT) today announced the launch of its new 4G GPS SmartSole in Sweden through its distribution partner Posifon AB. The upgraded GPS SmartSole introduction will be an important part of the national service agreement Posifon recently secured with major municipalities across Sweden related to providing home care, personal tracking and security for seniors. Initial shipments of the GPS SmartSole will be distributed to health care organizations, from memory care clinics to hospitals and social care organizations throughout Sweden. “We are excited to launch this next generation 4G Cat M1 GPS SmartSole in one of Europe’s most advanced health…

WednesdayJan 25, 2023 10:55 am

QualityStocksNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) to Host Q4 and FY 2022 Earnings Call

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, today announced that it will hold a conference call at 5:00 p.m. Eastern Time on Tuesday, Feb. 7, 2023, to discuss its results for the fourth quarter and full year ended Dec. 31, 2022. DoubleDown management will host a presentation followed by a question-and-answer period. Interested parties should visit https://ibn.fm/B8GNg to register for the call, after which they will be sent dial-in details and a unique access code. Attendees are asked to register a minimum of 15 minutes prior to the start of…

WednesdayJan 25, 2023 10:30 am

SideChannel Inc. (SDCH) to Provide Key Operational Updates and Strategic Priorities During Investor Day Virtual Event on February 15, 2023

The February 15, 2023 Investor Day virtual event will be hosted by the company’s President and CEO, Brian Haugli, and CFO, Ryan Polk Reports have shown an increase in cyberattacks due to the growth in network attack surfaces for in-office and remote workers who rely on cloud environments, mobile devices, software applications, and third-party suppliers to conduct business SideChannel’s newest product release, Enclave(TM), is a comprehensive cloud and network solution that enables IT teams to contain breaches faster, reduce network outages, minimize latency, and strengthen overall defensive security SideChannel (OTCQB: SDCH), a provider of cybersecurity services and technology, develops technologies…

WednesdayJan 25, 2023 10:24 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) $4.1M Placements Supported by Aegis Capital Corp. as Exclusive Placement Agent

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, recently announced the closing of both a registered direct and a private placement; the placements totaled approximately $4.1 million. Aegis Capital Corp. acted as exclusive placement agent for those placements. In the wealth management and investment banking business since 1984, Aegis has built a reputation for offering corporate finance and strategic advisory services to public and private companies across multiple sectors and regions. In addition, the company offers expert research and sales and trading services to institutional investors. Aegis provides a conflict-free service platform as well as…

WednesdayJan 25, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability to Meet Underserved Medical Needs

Bioavailability measures the amount of a substance that enters the bloodstream, with most oral routes providing lower amounts of the drug due to poor bioavailability Studies on nutrients show that not all the nutrients we ingest actually enter the bloodstream due to inhibiting factors in the digestive tract Lexaria’s patented DehydraTECH(TM) technology helps increase bioavailability for active pharmaceutical ingredients (“APIs”), which has been shown through various animal and human clinical studies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to improve bioavailability and how active pharmaceutical ingredients (“APIs”) enter the bloodstream…

WednesdayJan 25, 2023 9:00 am

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Set to Potentially Benefit as Renowned Gold Bug, Claude Bejet, Says Now is the Time to Invest in Precious Metals

Claude Bejet, a long-time precious metals investor and author of the Swiss Gold Letter, was interviewed on the sidelines of the recent Mines and Money Conference in London During his interview, Bejet commented on his optimism in regards to the precious metals complex as well as the considerable value held by junior mining companies Eloro Resources possesses a 100% option agreement on the Iska Iska deposit, a major polymetallic epithermal porphyry complex covering over 900 hectares of land The company is due to publish their initial assessment of Iska iska’s resource potential by March 2023, a process which Eloro are…

TuesdayJan 24, 2023 12:00 pm

9th Annual Podfest Expo(R) 2023 At Renaissance Orlando at SeaWorld(R)

World(R) on January 26-29, 2023, unites a community of international enthusiasts devoted to podcasting technology and general communication with the world through the medium of audio and video. Main stage sponsor SiriusXM will be represented at the 9th Annual Podfest Expo(R) 2023 supporting a community of creators whos’ origin began in 2013 as a meetup of 13 attendees. This year’s expo will be topping 1500+ Podcasters enjoying an immersive experience with over 200 Subject matter experts sharing their best practices The venue of the event is Renaissance Orlando at SeaWorld(R) - within walking distance of SeaWorld(R) Orlando and the Aquatica…

TuesdayJan 24, 2023 11:56 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company focused on developing novel treatments for primary and metastatic cancers in the brain and central nervous system, is enrolling patients in a phase 2 trial to evaluate the efficacy of its flagship drug candidate. The potentially pivotal trial will evaluate Berubicin for the treatment of glioblastoma multiforme (“GBM”), an aggressive brain tumor with an average overall survival rate of only 10-12 months. The company’s Chief Executive Officer John Climaco recently participated in the Virtual Investor “Ask the CEO” Event and discussed that enrollment in the trial was approaching 70 patients against a…

Site Search

Company Search